Mechanisms involved in the aging-induced vascular dysfunction

Frontiers in Physiology

Volumn 3 MAY, Issue , 2012, Pages

  El Assar, Mariam ^a   Angulo, Javier ^a,b   Vallejo, Susana ^c   Peiró, Concepción ^c   Sánchez Ferrer, Carlos F ^c   Rodríguez Mañas, Leocadio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Aging; Cardiovascular disease; Endothelial dysfunction; Inflammation; Nitric oxide; Oxidative stress; Senescence

Indexed keywords

EID: 84866363828     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00132     Document Type: Article

References (184)

1. Abbatecola, A. M., Paolisso, G., Fat-toretti, P., Evans, W. J., Fiore, V., Dicioccio, L., and Lattanzio, F. (2011). Discovering pathways of sar-copenia in older adults: a role for insulin resistance on mitochondria dysfunction. J. Nutr. Health Aging 15,890-895.
2. Ahlers, B. A., Parnell, M. M., Chin-Dusting, J. P., and Kaye, D. M. (2004). An age-related decline in endothelial function is not associated with alterations in L-arginine transport in humans. J. Hypertens. 22,321-327.
3. Albarwani, S., Al-Siyabi, S., Baomar, H., and Hassan, M. O. (2010). Exercise training attenuates ageing-induced BKCa channel downregulation in rat coronary arteries. Exp. Physiol. 95, 746-755.
4. Alcendor, R. R., Gao, S., Zhai, P., Zablocki, D., Holle, E., Yu, X., Tian, B., Wagner, T., Vatner, S. F., and Sadoshima, J. (2007). Sirt1 regulates aging and resistance to oxida-tive stress in the heart. Circ. Res. 100, 1512-1521.
5. Angulo, J., Cuevas, P., Fernandez, A., Gabancho, S., Videla, S., and Saenz De Tejada, I. (2003). Calcium dobesilate potentiates endothelium-derived hyperpolar-izing factor-mediated relaxation of human penile resistance arteries. Br. I Pharmacol. 139, 854-862.
6. Arenas, I. A., Xu, Y., and Davidge, S. T. (2006). Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-alpha antagonism. Am. J. Physiol. Heart Circ. Physiol. 290, H1259-H1263.
7. Aviv, H., Khan, M. Y., Skurnick, J., Okuda, K., Kimura, M., Gardner, J., Priolo, L., and Aviv, A. (2001). Age dependent aneuploidy and telom-ere length of the human vascular endothelium. Atherosclerosis 159, 281-287.
8. Barodka, V. M., Joshi, B. L., Berkowitz, D. E., Hogue, C. W. Jr., and Nyhan, D. (2011). Review article: implications of vascular aging. Anesth. Analg. 112, 1048-1060.
9. Barton, M., Cosentino, F., Brandes, R. P., Moreau, P., Shaw, S., and Luscher, T. E (1997). Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 30,817-824.
10. Benetos, A., Okuda, K., Lajemi, M., Kimura, M., Thomas, F., Skurnick, J., Labat, C., Bean, K., and Aviv, A. (2001). Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension 37, 381-385.
11. Benigni, A., Corna, D., Zoja, C., Son-zogni, A., Latini, R., Salio, M., Conti, S., Rottoli, D., Longaretti, L., Cassis, P., Morigi, M., Coffman, T. M., and Remuzzi, G. (2009). Disruption of the Ang II type 1 receptor promotes longevity in mice.J. Clin. Invest. 119, 524-530.
12. Bode-Boger, S. M., Muke, J., Surdacki, A., Brabant, G., Boger, R. H., and Frolich, J. C. (2003). Oral L-arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 8, 77-81.
13. Bode-Boger, S. M., Scalera, F., and Martens-Lobenhoffer, J. (2005). Asymmetric dimethylarginine (ADMA) accelerates cell senescence. Vasc. Med. 10(Suppl. 1),S65-S71.
14. Brandes, R. P., Fleming, I., and Busse, R. (2005). Endothelial aging. Cardio-vasc. Res. 66, 286-294.
15. Breitschopf, K., Zeiher, A. M., and Dim-meler, S. (2001). Pro-atherogenic factors induce telomerase inactiva-tion in endothelial cells through an Akt-dependent mechanism. FEBS Lett. 493,21-25.
16. Briasoulis, A., Tousoulis, D., Antoni-ades, C., Stefanadis, C., and Papa-georgiou, N. (2011). The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc. Ther. 29,125-139.
17. Briones, A. M., Montoya, N., Giraldo, J., and Vila, E. (2005). Ageing affects nitric oxide synthase, cyclooxyge-nase and oxidative stress enzymes expression differently in mesenteric resistance arteries. Auton. Autacoid Pharmacol. 25,155-162.
18. Cai, H., and Harrison, D. G. (2000). Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840-844.
19. Calado, R. T., and Young, N. S. (2009). Telomere diseases. N. Engl. J. Med. 361,2353-2365.
20. Cernadas, M. R., Sanchez De Miguel, L., Garcia-Duran, M., Gonzalez-Fernandez, F., Millas, I., Monton, M., Rodrigo, J., Rico, L., Fernandez, P., De Frutos, T., Rodriguez-Feo, J. A., Guerra, J., Caramelo, C., Casado, S., and Lopez, F. (1998). Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ. Res. 83, 279-286.
21. Chang, E. I., Loh, S. A., Ceradini, D. J., Lin, S. E., Bastidas, N., Aarabi, S., Chan, D. A., Freedman, M. L., Giac-cia, A. J., and Gurtner, G. C. (2007). Age decreases endothelial progenitor cell recruitment through decreases in hypoxia-inducible factor 1alpha stabilization during ischemia. Circulation 116,2818-2829.
22. Chen, J., Brodsky, S. V., Goligorsky, D. M., Hampel, D. J., Li, H., Gross, S. S., and Goligorsky, M. S. (2002). Gly-cated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ. Res. 90, 1290-1298.
23. Chen, J., Park, H. C., Patschan, S., Brodsky, S. V., Gealikman, O., Kuo, M. C., Li, H., Addabbo, F., Zhang, F., Nasjletti, A., Gross, S. S., and Goligorsky, M. S. (2007). Premature vascular senescence in metabolic syndrome: could it be prevented and reversed by a selenorganic antiox-idant and peroxynitrite scavenger ebselen? Drug Discov. Today Ther. Strateg. 4, 93-99.
24. Chung, H. Y., Kim, H. J., Kim, K. W., Choi, J. S., and Yu, B. P. (2002). Molecular inflammation hypothesis of aging based on the anti-aging mechanism of calorie restriction. Microsc. Res. Tech. 59,264-272.
25. Cooke, J. P. (2005). ADMA: its role in vascular disease. Vasc. Med. 10(Suppl. 1), S11-S17.
26. Csiszar, A., Labinskyy, N., Jimenez, R., Pinto, J. T., Ballabh, P., Losonczy, G., Pearson, K. J., De Cabo, R., and Ungvari, Z. (2009). Anti-oxidative and anti-inflammatory vasoprotec-tive effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech. Ageing Dev. 130, 518-527.
27. Csiszar, A., Labinskyy, N., Smith, K., Rivera, A., Orosz, Z., and Ungvari, Z. (2007). Vasculoprotective effects of anti-tumor necrosis factor-alpha treatment in aging. Am. J. Pathol. 170,388-398.
28. Csiszar, A., Ungvari, Z., Edwards, J. G., Kaminski, P., Wolin, M. S., Koller, A., and Kaley, G. (2002). Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ. Res. 90,1159-1166.
29. Csiszar, A., Ungvari, Z., Koller, A., Edwards, J. G., and Kaley, G. (2003). Aging-induced proinflam-matory shift in cytokine expression profile in coronary arteries. FASEB J. 17,1183-1185.
30. Csiszar, A., Ungvari, Z., Koller, A., Edwards, J. G., and Kaley, G. (2004). Proinflammatory pheno-type of coronary arteries promotes endothelial apoptosis in aging. Physiol. Genomics 17,21-30.
31. Cui, H., Kong, Y., and Zhang, H. (2012). Oxidative stress, mitochondrial dysfunction, and aging. J. Signal Trans-duct. 2012,646354.
32. d'Alessio, P. (2004). Aging and the endothelium. Exp. Gerontol. 39, 165-171.
33. De Meyer, T., Rietzschel, E. R., De Buyzere, M. L., Van Criekinge, W., and Bekaert, S. (2011). Telomere length and cardiovascular aging: the means to the ends? Ageing Res. Rev. 10,297-303.
34. de Sotomayor, M. A., Perez-Guerrero, C., Herrrera, M. D., Jimenez, L., Marin, R., Marhuenda, E., and Andriantsitohaina, R. (2005). Improvement of age-related endothelial dysfunction by sim-vastatin: effect on NO and COX pathways. Br. J. Pharmacol. 146, 1130-1138.
35. Donato, A. J., Black, A. D., Jablon-ski, K. L., Gano, L. B., and Seals, D. R. (2008). Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell 7, 805-812.
36. Donato, A. J., Eskurza, I., Silver, A. E., Levy, A. S., Pierce, G. L., Gates, P. E., and Seals, D. R. (2007). Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregula-tion of nuclear factor-kappaB. Circ. Res. 100, 1659-1666.
37. Donato, A. J., Gano, L. B., Eskurza, I., Silver, A. E., Gates, P. E., Jablonski, K., and Seals, D. R. (2009). Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol. 297, H425-H432.
38. Donato, A. J., Lesniewski, L. A., and Delp, M. D. (2005). The effects of aging and exercise training on endothelin-1 vasoconstrictor responses in rat skeletal muscle arterioles. Cardiovasc. Res. 66, 393-401.
39. Donato, A. J., Magerko, K. A., Law-son, B. R., Durrant, J. R., Lesniewski, L. A., and Seals, D. R. (2011). SIRT-1and vascular endothelial dysfunction with ageing in mice and humans. J. Physiol. (Lond.) 589, 4545-4554.
40. Donato, A. J., Uberoi, A., Bailey, D. M., Wray, D. W., and Richardson, R. S. (2010). Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly men. Am. J. Physiol. Heart Circ. Physiol. 298, H671-H678.
41. Dora, K. A., Gallagher, N. T., Mcneish, A., and Garland, C. J. (2008). Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries. Circ. Res. 102,1247-1255.
42. Epel, E. S., Merkin, S. S., Cawthon, R., Blackburn, E. H., Adler, N. E., Pletcher, M. J., and Seeman, T. E. (2009). The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 1, 81-88.
43. Erusalimsky, J. D. (2009). Vascular endothelial senescence: from mechanisms to pathophysiology. J. Appl. Physiol. 106, 326-332.
44. Erusalimsky, J.D., and Kurz,D.J. (2005). Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp. Gerontol. 40, 634-642.
45. Erusalimsky, J. D., and Skene, C. (2009). Mechanisms of endothelial senescence. Exp. Physiol. 94,299-304.
46. Eskurza, I., Kahn, Z. D., and Seals, D. R. (2006). Xanthine oxidase does not contribute to impaired peripheral conduit artery endothelium-dependent dilatation with ageing. J. Physiol. (Lond.) 571, 661-668.
47. Farsetti, A., Grasselli, A., Bacchetti, S., Gaetano, C., and Capogrossi, M. C. (2009). The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling. J. Appl. Physiol. 106, 333-337.
48. Ferrucci, L., Corsi, A., Lauretani, F., Bandinelli, S., Bartali, B., Taub, D. D., Guralnik, J. M., and Longo, D. L. (2005). The origins of age-related proinflammatory state. Blood 105, 2294-2299.
49. Franceschi, C., Bonafe, M., Valensin, S., Olivieri, F., De Luca, M., Otta-viani, E., and De Benedictis, G. (2000). Inflamm-aging. An evolutionary perspective on immunose-nescence. Ann. N. Y Acad. Sci. 908, 244-254.
50. Francia, P., Delli Gatti, C., Bachschmid, M., Martin-Padura, I., Savoia, C., Migliaccio, E., Pelicci, P. G., Schi-avoni, M., Luscher, T. F., Volpe, M., and Cosentino, F. (2004). Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation 110,2889-2895.
51. Gates, P. E., Boucher, M. L., Silver, A. E., Monahan, K. D., and Seals, D. R. (2007). Impaired flow-mediated dilation with age is not explained by L-arginine bioavail-ability or endothelial asymmetric dimethylarginine protein expression. J. Appl. Physiol. 102, 63-71.
52. Gaubert, M. L., Sigaudo-Roussel, D., Tartas, M., Berrut, G., Saumet, J. L., andFromy, B. (2007).Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice.J. Physiol. 585,617-626.
53. Goraca, A. (2004). Assessment of total antioxidant capacity in human plasma. Folia Med. (Plovdiv) 46, 16-21.
54. Goto, K., Fujii, K., Kansui, Y., and Iida, M. (2004). Changes in endothelium-derived hyperpolarizing factor in hypertension and ageing: response to chronic treatment with renin-angiotensin system inhibitors. Clin. Exp. Pharmacol. Physiol. 31, 650-655.
55. Goto, K., Fujii, K., Onaka, U., Abe, I., and Fujishima, M. (2000). Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction. Hypertension 36, 581-587.
56. Griese, D. P., Ehsan, A., Melo, L. G., Kong, D., Zhang, L., Mann, M. J., Pratt, R. E., Mulligan, R. C., and Dzau, V. J. (2003). Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710-2715.
57. Guarente, L. (2011). Franklin H. Epstein lecture: sirtuins, aging, and medicine. N. Engl. J. Med. 364, 2235-2244.
58. Guzik, T. J., Mussa, S., Gastaldi, D., Sad-owski, J., Ratnatunga, C., Pillai, R., and Channon, K. M. (2002). Mechanisms of increased vascular super-oxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide syn-thase. Circulation 105, 1656-1662.
59. Haendeler, J., Hoffmann, J., Diehl, J. F., Vasa, M., Spyridopoulos, I., Zeiher, A. M., and Dimmeler, S. (2004). Antioxidants inhibit nuclear export of telomerase reverse tran-scriptase and delay replicative senescence of endothelial cells. Circ. Res. 94, 768-775.
60. Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H. Jr., Heimovitz, H., Cohen, H. J., and Wallace, R. (1999). Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106, 506-512.
61. Hayashi, T., Matsui-Hirai, H., Miyazaki-Akita, A., Fukatsu, A., Funami, J., Ding, Q. F., Kamalanathan, S., Hat-tori, Y., Ignarro, L. J., and Iguchi, A. (2006). Endothelial cellular senescence is inhibited by nitric oxide: implications in atherosclerosis associated with menopause and diabetes. Proc. Natl. Acad. Sci. U.S.A. 103, 17018-17023.
62. Hayashi, T., Yano, K., Matsui-Hirai, H., Yokoo, H., Hattori, Y., and Iguchi, A. (2008). Nitric oxide and endothelial cellular senescence. Pharmacol. Ther. 120,333-339.
63. Haynes,W. G., Strachan, F. E.,andWebb, D. J. (1995). Endothelin ETA and ETB receptors cause vasoconstric-tion of human resistance and capacitance vessels in vivo. Circulation 92, 357-363.
64. Heymes, C., Habib, A., Yang, D., Math-ieu, E., Marotte, F., Samuel, J., and Boulanger, C. M. (2000). Cyclo-oxygenase-1 and -2 contribution to endothelial dysfunction in ageing. Br. J. Pharmacol. 131, 804-810.
65. Higashi, Y., Sasaki, S., Nakagawa, K., Kimura, M., Noma, K., Hara, K., Jitsuiki, D., Goto, C., Oshima, T., Chayama, K., and Yoshizumi, M. (2006). Tetrahydrobiopterin improves aging-related impairment of endothelium-dependent vasodi-lation through increase in nitric oxide production. Atherosclerosis 186, 390-395.
66. Hilgers, R. H., and Webb, R. C. (2007). Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am. J. Physiol. Heart. Circ. Physiol. 292, H2275-H2284.
67. Hoenig, M. R., Bianchi, C., Rosen-zweig, A., and Sellke, F. W (2008). Decreased vascular repair and neo-vascularization with ageing: mechanisms and clinical relevance with an emphasis on hypoxia-inducible factor-1. Curr. Mol. Med. 8,754-767.
68. Holowatz, L. A., Thompson, C. S., and Kenney, W. L. (2006). L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin. J. Physiol. (Lond.) 574, 573-581.
69. Idris Khodja, N., Chataigneau, T., Auger, C., and Schini-Kerth, V. B. (2012). Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system. PLoS ONE 7, e32039. doi:10.1371/journal.pone.0032039
70. Imanishi, T., Hano, T., and Nishio, I. (2005a). Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxida-tive stress. J. Hypertens. 23, 97-104.
71. Imanishi, T., Moriwaki, C., Hano, T., and Nishio, I. (2005b). Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J. Hypertens. 23, 1831-1837.
72. Jablonski, K. L., Seals, D. R., Eskurza, I., Monahan, K. D., and Donato, A. J. (2007). High-dose ascorbic acid infusion abolishes chronic vasocon-striction and restores resting leg blood flow in healthy older men. J. Appl. Physiol. 103,1715-1721.
73. Kansui, Y., Fujii, K., Goto, K., Abe, I., and Iida, M. (2002). Angiotensin II receptor antagonist improves age-related endothelial dysfunction. J. Hypertens. 20, 439-446.
74. Karshovska, E., Zernecke, A., Sevilmis, G., Millet, A., Hristov, M., Cohen, C D., Schmid, H., Krotz, F., Sohn, H. Y., Klauss, V., Weber, C., and Schober, A. (2007). Expression of HIF-1alpha in injured arteries con trols SDF-1alpha mediated neoin-tima formation in apolipoprotein E deficient mice. Arterioscler. Thromb. Vasc. Biol. 27, 2540-2547.
75. Keymel, S., Kalka, C., Rassaf, T., Yeghi-azarians, Y., Kelm, M., and Heiss, C. (2008). Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening. Basic Res. Cardiol. 103,582-586.
76. Kim, D. H., Newman, A. B., Hajjar, I., Strotmeyer, E. S., Klein, R., Newton, E., Sarnak, M. J., Burke, G. L., and Lipsitz, L. A. (2011). Retinal microvascular signs and functional loss in older persons: the cardiovascular health study. Stroke 42, 1589-1595.
77. Kim, S. F., Huri, D. A., and Snyder, S. H. (2005). Inducible nitric oxide syn-thase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310, 1966-1970.
78. Kimura, S., Zhang, G. X.,Nishiyama, A., Shokoji, T., Yao, L., Fan, Y. Y., Rahman, M., Suzuki, T., Maeta, H., and Abe, Y (2005). Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardio-protection of ischemic reperfusion injury by angiotensin II. Hypertension 45, 860-866.
79. Kirton, J. P., and Xu, Q. (2010). Endothelial precursors in vascular repair. Microvasc. Res. 79, 193-199.
80. Kotsis, V., Stabouli, S., Karafillis, I., and Nilsson, P. (2011). Early vascular aging and the role of central blood pressure. J. Hypertens. 29, 1847-1853.
81. Korzick, D. H., Muller-Delp, J. M., Dougherty, P., Heaps, C. L., Bowles, D K., and Krick, K. K. (2005). Exag gerated coronary vasoreactivity to endothelin-1 in aged rats: role of protein kinase C. Cardiovasc Res. 66, 384-392.
82. Kurz, D. J., Decary, S., Hong, Y., Trivier, E., Akhmedov, A., and Erusalimsky, J. D. (2004). Chronic oxi dative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J. Cell Sci. 117,2417-2426.
83. Kushner, E. J., Van Guilder, G. P., Mace-neaney, O. J., Cech, J. N., Stauf-fer, B. L., and Desouza, C. A. (2009). Aging and endothelial progenitor cell telomere length in healthy men. Clin. Chem. Lab. Med. 47, 47-50.
84. Lassegue, B., and Griendling, K. K. (2010). NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661.
85. Laursen, J. B., Somers, M., Kurz, S., Mccann, L., Warnholtz, A., Freeman, B. A., Tarpey, M., Fukai, T., and Harrison, D. G. (2001). Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxyni-trite and tetrahydrobiopterin. Circulation 103,1282-1288.
86. LeBlanc, A. J., Shipley, R. D., Kang, L. S., and Muller-Delp, J. M. (2008). Age impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 295, H2280-H2288.
87. Li, L., Gao, P., Zhang, H., Chen, H., Zheng, W., Lv, X., Xu, T., Wei, Y., Liu, D., and Liang, C. (201 1a). SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy. Acta Biochim. Biophys. Sin. (Shanghai) 43, 103-109.
88. Li, L., Zhang, H. N., Chen, H. Z., Gao, P., Zhu, L. H., Li, H. L., Lv, X., Zhang, Q. J., Zhang, R., Wang, Z., She, Z. G., Wei, Y. S., Du, G. H., Liu, D. P., and Liang, C. C. (2011b). SIRT1 actsasamodulatorofneointimafor-mation following vascular injury in mice. Circ. Res. 108, 1180-1189.
89. Long, D. A., Newaz, M. A., Prabhakar, S. S., Price, K. L., Truong, L. D., Feng, L., Mu, W., Oyekan, A. O., and Johnson, R. J. (2005). Loss of nitric oxide and endothelial-derivedhyperpolarizing factor-mediated responses in aging. KidneyInt. 68,2154-2163.
90. Loscalzo, J. (2000). What we know and don't know about L-arginine and NO. Circulation 101,2126-2129.
91. Lüscher, T. F., and Barton, M. (2000). Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs. Circulation 102, 2434-2440.
92. Mackenzie, A., Cooper, E. J., and Dow-ell, F. J. (2008). Differential effects of glucose on agonist-induced relaxations in human mesenteric and subcutaneous arteries. Br. J. Pharmacol. 153,480-487.
93. Maeda, S., Tanabe, T., Miyauchi, T., Otsuki, T., Sugawara, J., Iemitsu, M., Kuno, S., Ajisaka, R., Yamaguchi, I., and Matsuda, M. (2003). Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J. Appl. Physiol. 95,336-341.
94. Malinin, N. L., West, X. Z., and Byzova, T. V. (2011). Oxidation as "the stress of life." Aging (Albany NY) 3, 906-910.
95. Masaki, T., Kimura, S., Yanagisawa, M., and Goto, K. (1991). Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84,1457-1468.
96. Matz, R. L., and Andriantsitohaina, R. (2003). Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 20, 527-550.
97. Matz, R. L., De Sotomayor, M. A., Schott, C., Stoclet, J. C., and Andriantsitohaina, R. (2000). Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. Br. J. Pharmacol. 131, 303-311.
98. Mecocci, P., Polidori, M. C., Troiano, L., Cherubini, A., Cecchetti, R., Pini, G., Straatman, M., Monti, D., Stahl, W., Sies, H., Franceschi, C., and Senin, U. (2000). Plasma antioxidants and longevity: a study on healthy centenarians. Free Radic. Biol. Med. 28, 1243-1248.
99. Milstien, S., and Katusic, Z. (1999). Oxidation of tetrahydrobiopterin by peroxynitrite: implications for vascular endothelial function. Biochem. Biophys. Res. Commun. 263, 681-684.
100. Minamino, T., and Komuro, I. (2007). Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100, 15-26.
101. Minamino, T., Miyauchi, H., Yoshida, T., Tateno, K., and Komuro, I. (2004). The role of vascular cell senescence in atherosclerosis: antisenescence as a novel therapeutic strategy for vascular aging. Curr. Vasc. Pharmacol. 2, 141-148.
102. Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J., and Sunagawa, K. (2008). SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 28,1263-1269.
103. Mollnau, H., Wendt, M., Szocs, K., Lassegue, B., Schulz, E., Oelze, M., Li, H., Bodenschatz, M., August, M., Kleschyov, A. L., Tsilimingas, N., Walter, U., Forstermann, U., Mein-ertz, T., Griendling, K., and Mun-zel, T. (2002). Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 90, E58-E65.
104. Morris, B. J. (2005). The scorching breath of angiotensin. J. Hypertens. 23, 33-35.
105. Mukai, Y., Shimokawa, H., Higashi, M., Morikawa, K., Matoba, T., Hiroki, J., Kunihiro, I., Talukder, H. M., and Takeshita, A. (2002). Inhibition of renin-angiotensin system ameliorates endothelial dysfunction associated with aging in rats. Arterioscler. Thromb. Vasc. Biol. 22, 1445-1450.
106. Munzel, T., Daiber, A., Ullrich, V., and Mulsch, A. (2005). Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guany-lyl cyclase and the cGMP-dependent protein kinase. Arterioscler. Thromb. Vasc. Biol. 25, 1551-1557.
107. Najjar, S. S., Scuteri, A., and Lakatta, E. G. (2005). Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 46,454-462.
108. Nakashima, M., Mombouli, J. V., Taylor, A. A., and Vanhoutte, P. M. (1993). Endothelium-dependent hyperpo-larization caused by bradykinin in human coronary arteries. J. Clin. Invest. 92,2867-2871.
109. Nevado, J., Vallejo, S., El-Assar, M., Peiro, C., Sanchez-Ferrer, C. F., and Rodriguez-Manas, L. (2006). Changes in the human peritoneal mesothelial cells during aging. Kidney Int. 69,313-322.
110. Newaz, M. A., Yousefipour, Z., and Oyekan, A. (2006). Oxidative stress-associated vascular aging is xan-thine oxidase-dependent but not NAD(P)H oxidase-dependent. J. Cardiovasc. Pharmacol. 48, 88-94.
111. Ogami, M., Ikura, Y., Ohsawa, M., Mat-suo, T., Kayo, S., Yoshimi, N., Hai, E., Shirai, N., Ehara, S., Komatsu, R., Naruko, T., and Ueda, M. (2004). Telomere shortening in human coronary artery diseases. Arterioscler. Thromb. Vasc. Biol. 24, 546-550.
112. Ota, H., Akishita, M., Eto, M., Iijima, K., Kaneki, M., and Ouchi, Y. (2007). Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol Cell Cardiol. 43,571-579.
113. Ota, H., Eto, M., Ako, J., Ogawa, S., Iijima, K., Akishita, M., and Ouchi, Y. (2009). Sirolimus and everolimus induce endothelial cellular senescence via sirtuin 1 down-regulation: therapeutic implication of cilosta-zol after drug-eluting stent implantation. J. Am. Coll. Cardiol. 53, 2298-2305.
114. Ota, H., Eto, M., Kano, M. R., Ogawa, S., Iijima, K., Akishita, M., and Ouchi, Y. (2008). Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 1634-1639.
115. Ota, H., Eto, M., Ogawa, S., Iijima, K., Akishita, M., and Ouchi, Y. (2010). SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J. Ath-eroscler. Thromb. 17, 431-435.
116. Pacher, P., Beckman, J. S., and Liaudet, L. (2007). Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
117. Pang, C. Y., Ma, Y. S., and Wei, Y. U. (2008). MtDNA mutations, functional decline and turnover of mitochondria in aging. Front. Biosci. 13, 3661-3675.
118. Panza, F., D'Introno, A., Colacicco, A. M., Capurso, C., Parigi, A. D., Capurso, S. A., Caselli, R. J., Pilotto, A., Scafato, E., Capurso, A., and Sol-frizzi, V (2006). Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol. Aging 27, 933-940.
119. Pascoal, I. F., and Umans, J. G. (1996). Effect of pregnancy on mechanisms of relaxation in human omental microvessels. Hypertension 28, 183- 187.
120. Pasquier, D., and Dias, S. (2010). Endothelial progenitor cells: hope beyond controversy. Curr. Cancer Drug Targets 10, 914-921.
121. Patschan, S., Chen, J., Polotskaia, A., Mendelev, N., Cheng, J., Patschan, D., and Goligorsky, M. S. (2008). Lipid mediators of autophagy in stress-induced premature senescence of endothelial cells. Am. J. Physiol. Heart. Circ. Physiol. 294, H1119-H1129.
122. Patschan, S., and Goligorsky, M. S. (2008). Autophagy: the missing link between non-enzymatically glycated proteins inducing apoptosis and premature senescence of endothelial cells? Autophagy 4, 521-523.
123. Potente, M., and Dimmeler, S. (2008). NO targets SIRT1: a novel signaling network in endothelial senescence. Arterioscler. Thromb. Vasc. Biol. 28, 1577-1579.
124. Rajagopalan, S., Brook, R., Mehta, R. H., Supiano, M., and Pitt, B. (2002). Effect of losartan in aging-related endothelial impairment. Am. J. Cardiol. 89, 562-566.
125. Rajagopalan, S., Kariisa, M., Delle-grottaglie, S., Bard, R. L., Kehrer, C., Matlow, S., Daley, W., Pitt, B., and Brook, R. (2006). Angiotensin receptor blockade improves vascular compliance in healthy normotensive elderly individuals: results from a randomized double-blind placebo-controlled trial. J. Clin. Hypertens. (Greenwich) 8, 783-790.
126. Rajapakse, A. G., Yepuri, G., Carvas, J. M., Stein, S., Matter, C. M., Scerri, I., Ruffieux, J., Montani, J. P., Ming, X. E, and Yang, Z. (2011). Hyperactive S6K1 mediates oxidative stress and endothelial dysfunction in aging: inhibition by resveratrol. PLoS One 6,e19237.
127. Resch, T., Pircher, A., Kähler, C. M., Pratschke, J., and Hilbe, W. (2011). Endothelial progenitor cells: current issues on characterization and challenging clinical applications. Stem Cell Rev. doi: 10.1007/s12015-011-9332-9. [Epub ahead of print].
128. Rippe, C., Lesniewski, L., Connell, M., LaRocca, T., Donato, A. J., and Seals, D. (2010). Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 9, 304-312.
129. Endothelial dysfunction in aged humans is related with oxidative stress and vascular inflammation
130. Rosso, A., Balsamo, A., Gambino, R., Dentelli, P., Falcioni, R., Cassader, M., Pegoraro, L., Pagano, G., and Brizzi, M. E (2006). p53 Mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. J. Biol. Chem. 281, 4339-4347.
131. Sagach,V., Bondarenko, A., Bazilyuk, O., and Kotsuruba, A. (2006). Endothelial dysfunction: possible mechanisms and ways of correction. Exp. Clin. Cardiol. 11, 107-110.
132. Sanchez-Guijo, E M., Oterino, E., Barbado, M. V., Carrancio, S., Lopez-Holgado, N., Muntion, S., Hernandez-Campo, P., Sanchez-Abarca, L. I., Perez-Simon, J. A., San Miguel, J. F., Briñon, J. G., and del Cañizo, M. C. (2010). Both CD133(+) cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells. Cell Transplant. 19, 103-112.
133. Santhanam, L., Christianson, D. W., Nyhan, D., and Berkowitz, D. E. (2008). Arginase and vascular aging. J.Appl. Physiol. 105,1632-1642.
134. Santhanam, L., Lim, H. K., Miriel, V., Brown, T., Patel, M., Bal-anson, S., Ryoo, S., Anderson, M., Irani, K., Khanday, F., Di Costanzo, L., Nyhan, D., Hare, J. M., Christianson, D. W., Rivers, R., Shoukas, A., and Berkowitz, D. E. (2007). Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ. Res. 101, 692-702.
135. Scalera, F., Martens-Lobenhoffer, J., Bukowska, A., Lendeckel, U., Tager, M., and Bode-Boger, S. M. (2008). Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxi-some proliferator activated receptor gamma signaling during endothelial aging. Hypertension 51, 696-703.
136. Schiffrin, E. L. (2008). Oxidative stress, nitric oxide synthase, and superox-ide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. Hypertension 51, 31-32.
137. Schrage, W. G., Eisenach, J. H., and Joyner, M. J. (2007). Ageing reduces nitric-oxide- and prostaglandin-mediated vasodilatation in exercising humans. J. Physiol. (Lond.) 579, 227-236.
138. Schulze, F., Maas, R., Freese, R., Schwed-helm, E., Silberhorn, E., and Boger, R. H. (2005). Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur. J. Clin. Invest. 35, 622-626.
139. Sedding, D., and Haendeler, J. (2007). Do we age on Sirt1 expression? Circ. Res. 100, 1396-1398.
140. Seo, B., Oemar, B. S., Siebenmann, R., Von Segesser, L., and Luscher, T. E (1994). Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89, 1203-1208.
141. Shi, Y., Man, R. Y., and Vanhoutte, P. M. (2008). Two isoforms of cyclooxygenase contribute to augmented endothelium-dependent contractions in femoral arteries of 1-year-old rats. Acta Pharmacol. Sin. 29, 185-192.
142. Simons, L. A., Von Konigsmark, M., Simons, J., Stocker, R., and Celerma-jer, D. S. (1999). Vitamin Eingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 143, 193-199.
143. Soucy, K. G., Ryoo, S., Benjo, A., Lim, H. K., Gupta, G., Sohi, J. S., Elser, J., Aon, M. A., Nyhan, D., Shoukas, A. A., and Berkowitz, D. E. (2006). Impaired shear stress-induced nitric oxide production through decreased NOS phosphory-lation contributes to age-related vascular stiffness. J. Appl. Physiol. 101, 1751-1759.
144. Stegbauer, J., and Coffman, T. M. (2011). New insights into angiotensin receptor actions: from blood pressure to aging. Curr. Opin. Nephrol. Hypertens. 20, 84-88.
145. Stewart, K. G., Zhang, Y., and Davidge, S. T. (2000). Aging increases PGHS-2-dependent vasoconstriction in rat mesenteric arteries. Hypertension 35, 1242-1247.
146. Sun, D., Huang, A., Yan, E. H., Wu, Z., Yan, C., Kaminski, P. M., Oury, T. D., Wolin, M. S., and Kaley, G. (2004). Reduced release of nitric oxide to shear stress in mesenteric arteries of aged rats. Am. J. Physiol. Heart Circ. Physiol. 286, H2249-H2256.
147. Taddei, S., Virdis, A., Mattei, P., Ghi-adoni, L., Fasolo, C. B., Sudano, I., and Salvetti, A. (1997). Hypertension causes premature aging of endothelial function in humans. Hypertension 29, 736-743.
148. Takamiya, M., Okigaki, M., Jin, D., Takai, S., Nozawa, Y., Adachi, Y., Urao, N., Tateishi, K., Nomura, T., Zen, K., Ashihara, E., Miyazaki, M., Tatsumi, T., Takahashi, T., and Matsubara, H. (2006). Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler. Thromb. Vasc. Biol. 26,751-757.
149. Tang, E. H., and Vanhoutte, P. M. (2008). Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertension. Physiol. Genomics 32, 409-418.
150. Thijssen, D. H., Rongen, G. A., Van Dijk, A., Smits, P., and Hopman, M. T. (2007). Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. J. Appl. Physiol. 103, 852-857.
151. Toda, N. (2012). Age-related changes in endothelial function and blood flow regulation. Pharmacol. Ther. 133, 159-176.
152. Touyz, R. M. (2003). Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev. Cardiovasc. Ther. 1, 91-106.
153. Tsukahara, H., Ende, H., Magazine, H. I., Bahou, W. F., and Goligorsky, M. S. (1994). Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J. Biol. Chem. 269,21778-21785.
154. Ungvari, Z., Buffenstein, R., Austad, S. N., Podlutsky, A., Kaley, G., and Csiszar, A. (2008). Oxidative stress in vascular senescence: lessons from successfully aging species. Front. Biosci. 13, 5056-5070.
155. Ungvari, Z., Csiszar, A., and Kaley, G. (2004). Vascular inflammation in aging. Herz 29, 733-740.
156. Ungvari, Z., Kaley, G., De Cabo, R., Son-ntag, W. E., and Csiszar, A. (2010a). Mechanisms of vascular aging: new perspectives. J. Gerontol. A Biol. Sci. Med. Sci. 65, 1028-1041.
157. Ungvari, Z.,Sonntag,W. E., and Csiszar, A. (2010b). Mitochondria and aging in the vascular system. J. Mol. Med. 88, 1021-1027.
158. Upmacis, R. K., Deeb, R. S., and Hajjar, D. P. (2006). Oxidative alterations of cyclooxygenase during athero-genesis. Prostaglandins Other Lipid Mediat. 80, 1-14.
159. Urakami-Harasawa, L., Shimokawa, H., Nakashima, M., Egashira, K., and Takeshita, A. (1997). Importance of endothelium-derived hyperpolariz-ing factor in human arteries. J. Clin. Invest. 100,2793-2799.
160. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., and Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84.
161. van Bussel, B. C., Schouten, F., Henry, R. M., Schalkwijk, C. G., De Boer, M. R., Ferreira, I., Smulders, Y M., Twisk, J. W., and Stehouwer, C. D. (2011). Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 58,588-595.
162. van der Loo, B., Labugger, R., Skep-per, J. N., Bachschmid, M., Kilo, J., Powell, J. M., Palacios-Callender, M., Erusalimsky, J. D., Quaschning, T., Malinski, T., Gygi, D., Ullrich, V., and Luscher, T. E (2000). Enhanced peroxynitrite formation is associated with vascular aging. J. Exp. Med. 192, 1731-1744.
163. Van Guilder, G. P., Westby, C. M., Greiner, J. J., Stauffer, B. L., and Desouza, C. A. (2007). Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50, 403-409.
164. Vanhoutte, P. M., Feletou, M., and Taddei, S. (2005). Endothelium-dependent contractions in hypertension. Br. J. Pharmacol. 144, 449-458.
165. Vasa, M., Breitschopf, K., Zeiher, A. M., and Dimmeler, S. (2000). Nitric oxide activates telomerase and delays endothelial cell senescence. Circ. Res. 87, 540-542.
166. Vasquez-Vivar, J., Kalyanaraman, B., and Martasek, P. (2003). The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic. Res. 37, 121-127.
167. Virdis, A., Ghiadoni, L., Giannarelli, C., and Taddei, S. (2010). Endothelial dysfunction and vascular disease in later life. Maturitas 67, 20-24.
168. Volpato, S., Guralnik, J. M., Ferrucci, L., Balfour, J., Chaves, P., Fried, L. P., and Harris, T. B. (2001). Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103, 947-953.
169. Walker, A. E., Seibert, S. M., Donato, A. J., Pierce, G. L., and Seals, D. R. (2010). Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension 55, 363-369.
170. Wang, C. Y., Kim, H. H., Hiroi, Y., Sawada, N., Salomone, S., Benjamin, L. E., Walsh, K., Moskowitz, M. A., and Liao, J. K. (2009). Obesity increases vascular senescence and susceptibility to ischemic injury through chronic activation of Akt and mTOR. Sci. Signal 2, ra11.
171. Wang, M., Takagi, G., Asai, K., Resuello, R. G., Natividad, F. F., Vatner, D. E., Vatner, S. F., and Lakatta, E. G. (2003). Aging increases aortic MMP-2 activity and angiotensin II in non-human primates. Hypertension 41, 1308-1316.
172. Wang, M., Zhang, J., Jiang, L. Q., Spinetti, G., Pintus, G., Monticone, R., Kolodgie, F. D., Virmani, R., and Lakatta, E. G. (2007). Proinflamma-tory profile within the grossly normal aged human aortic wall. Hypertension 50,219-227.
173. Watson, N. L., Sutton-Tyrrell, K., Youk, A O., Boudreau, R. M., Mackey, R. H., Simonsick, E. M., Rosano, C., Hardy, S. E., Windham, B. G., Harris, T. B., Najjar, S. S., Lakatta, E. G., Atkinson, H. H., Johnson, K. C., Bauer, D. C., and Newman, A. B. (2011). Arterial stiffness and gait speed in older adults with and with out peripheral arterial disease. Am. J. Hypertens. 24, 90-95.
174. Weiss, E. P., and Fontana, L. (2011). Caloric restriction: powerful protection for the aging heart and vas-culature. Am. J. Physiol Heart Circ. Physiol. 301,H1205-H1219.
175. Williamson, K., Stringer, S. E., and Alexander, M. Y. (2012). Endothelial progenitor cells enter the aging arena. Front. Physiol. 3:30. doi:10.3389/fphys.2012.00030
176. Wong, S. L., Leung, F. P., Lau, C. W., Au, C. L., Yung, L. M., Yao, X., Chen, Z. Y., Vanhoutte, P. M., Gollasch, M., and Huang, Y. (2009). Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ. Res. 104, 228-235.
177. Wray, D. W., Nishiyama, S. K., Harris, R. A., Zhao, J., Mcdaniel, J., Fjeldstad, A. S., Witman, M. A., Ives, S. J., Barrett-O'keefe, Z., and Richardson, R. S. (2012). Acute reversal of endothelial dysfunction in the elderly after antioxi-dant consumption. Hypertension 59, 818-824.
178. Yamagishi, S., and Matsui, T. (2011). Nitric oxide, a janus-faced therapeutic target for diabetic microangiopathy-friend or foe? Pharmacol. Res. 64, 187-194.
179. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., and Masaki, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332,411-415.
180. Yang, Y M., Huang, A., Kaley, G., and Sun, D. (2009a). eNOS uncoupling and endothelial dysfunction in aged vessels. Am. J. Physiol. Heart Circ. Physiol. 297, H1829-H1836.
181. Yang, Z., Huang, X., Jiang, H., Zhang, Y., Liu, H., Qin, C., Eisner, G. M., Jose, P. A., Rudolph, L., and Ju, Z. (2009b). Short telomeres and prognosis of hypertension in a Chinese population. Hypertension 53, 639-645.
182. Yu,B. P., and Chung, H.Y (2006). Adaptive mechanisms to oxidative stress during aging. Mech. AgeingDev. 127, 436-443.
183. Yuan, Q., Peng, J., Liu, S. Y., Wang, C. J., Xiang, D. X., Xiong, X. M., Hu, C. P., and Li, Y. J. (2010). Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway. Clin. Exp. Pharmacol. Physiol. 37, 630-635.
184. Zou, M. H., Shi, C., and Cohen, R. A. (2002). Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109, 817-826.